NCT06208748: SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST |
|
|
| Recruiting | 2 | 40 | US | Bezuclastinib in combination with sunitinib | Sarcoma Alliance for Research through Collaboration, Cogent Biosciences, Inc., Dana-Farber Cancer Institute, The Life Raft Group | Gastrointestinal Stromal Tumors, GIST | 06/26 | 06/27 | | |